Current spectrum and outcomes of infarct-related cardiogenic shock: insights from the CULPRIT-SHOCK registry and randomized controlled trial

We analysed consecutive patients with acute myocardial infarction complicated by cardiogenic shock (CS) who were enrolled into the CULPRIT-SHOCK randomized controlled trial (RCT) and those with exclusion criteria who were included into the accompanying registry.In total, 1075 patients with infarct-r...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Zeymer, Uwe (VerfasserIn) , Heer, Tobias (VerfasserIn) , Ouarrak, Taoufik (VerfasserIn) , Akın, Ibrahim (VerfasserIn) , Noc, Marko (VerfasserIn) , Stepinska, Janina (VerfasserIn) , Oldroyd, Keith (VerfasserIn) , Serpytis, Pranas (VerfasserIn) , Montalescot, Giles (VerfasserIn) , Huber, Kurt (VerfasserIn) , Windecker, Stephan (VerfasserIn) , Savonitto, Stefano (VerfasserIn) , Vrints, Christiaan (VerfasserIn) , Schneider, Steffen (VerfasserIn) , Desch, Steffen (VerfasserIn) , Thiele, Holger (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: April 2024
In: European heart journal - acute cardiovascular care
Year: 2024, Jahrgang: 13, Heft: 4, Pages: 335-346
ISSN:2048-8734
DOI:10.1093/ehjacc/zuae020
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1093/ehjacc/zuae020
Volltext
Verfasserangaben:Uwe Zeymer, Tobias Heer, Taoufik Ouarrak, Ibrahim Akin, Marko Noc, Janina Stepinska, Keith Oldroyd, Pranas Serpytis, Giles Montalescot, Kurt Huber, Stephan Windecker, Stefano Savonitto, Christiaan Vrints, Steffen Schneider, Steffen Desch, and Holger Thiele, on behalf of the CULPRIT-SHOCK Investigators

MARC

LEADER 00000caa a2200000 c 4500
001 1899443932
003 DE-627
005 20241205164946.0
007 cr uuu---uuuuu
008 240823s2024 xx |||||o 00| ||eng c
024 7 |a 10.1093/ehjacc/zuae020  |2 doi 
035 |a (DE-627)1899443932 
035 |a (DE-599)KXP1899443932 
035 |a (OCoLC)1475309136 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Zeymer, Uwe  |e VerfasserIn  |0 (DE-588)1163486884  |0 (DE-627)1027835694  |0 (DE-576)508027608  |4 aut 
245 1 0 |a Current spectrum and outcomes of infarct-related cardiogenic shock  |b insights from the CULPRIT-SHOCK registry and randomized controlled trial  |c Uwe Zeymer, Tobias Heer, Taoufik Ouarrak, Ibrahim Akin, Marko Noc, Janina Stepinska, Keith Oldroyd, Pranas Serpytis, Giles Montalescot, Kurt Huber, Stephan Windecker, Stefano Savonitto, Christiaan Vrints, Steffen Schneider, Steffen Desch, and Holger Thiele, on behalf of the CULPRIT-SHOCK Investigators 
264 1 |c April 2024 
300 |b Illustrationen 
300 |a 12 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Veröffentlicht: 13. Februar 2024 
500 |a Gesehen am 23.08.2024 
520 |a We analysed consecutive patients with acute myocardial infarction complicated by cardiogenic shock (CS) who were enrolled into the CULPRIT-SHOCK randomized controlled trial (RCT) and those with exclusion criteria who were included into the accompanying registry.In total, 1075 patients with infarct-related CS were screened for CULPRIT-SHOCK in 83 specialized centres in Europe; 369 of them had exclusion criteria for the RCT and were enrolled into the registry. Patients were followed over 1 year. The mean age was 68 years and 260 (25%) were women. 13.5%, 30.9%, and 55.6% had one-vessel, two-vessel, and three-vessel coronary artery disease (CAD), respectively. Significant left main (LM) coronary artery stenosis was present in 8.0%. 54.2% of the patients had cardiac arrest before admission. Thrombolysis in myocardial infarction (TIMI) 3 patency of the infarct vessel after percutaneous coronary intervention was achieved in 83.6% of all patients. Mechanical circulatory support was applied in one-third of patients. Total mortality after 30 days and 1 year was 47.6% and 52.9%. Mortality after 1 year was highest in patients with LM coronary artery stenosis (63.5%), followed by three-vessel (56.6%), two-vessel (49.8%), and one-vessel CAD (38.6%), respectively. Mechanical complications were rare (21/1008; 2.1%) but associated with a high mortality of 66.7% after 1 year.In specialized centres in Europe, short- and long-term mortality of patients with infarct-related CS treated with an invasive strategy is still high and mainly depends on the extent of CAD. Therefore, there is still a need for improvement of care to improve the prognosis of infarct-related CS. 
700 1 |a Heer, Tobias  |e VerfasserIn  |4 aut 
700 1 |a Ouarrak, Taoufik  |e VerfasserIn  |4 aut 
700 1 |a Akın, Ibrahim  |d 1978-  |e VerfasserIn  |0 (DE-588)132322293  |0 (DE-627)521039010  |0 (DE-576)299074366  |4 aut 
700 1 |a Noc, Marko  |e VerfasserIn  |4 aut 
700 1 |a Stepinska, Janina  |e VerfasserIn  |4 aut 
700 1 |a Oldroyd, Keith  |e VerfasserIn  |4 aut 
700 1 |a Serpytis, Pranas  |e VerfasserIn  |4 aut 
700 1 |a Montalescot, Giles  |e VerfasserIn  |4 aut 
700 1 |a Huber, Kurt  |e VerfasserIn  |4 aut 
700 1 |a Windecker, Stephan  |e VerfasserIn  |4 aut 
700 1 |a Savonitto, Stefano  |e VerfasserIn  |4 aut 
700 1 |a Vrints, Christiaan  |e VerfasserIn  |4 aut 
700 1 |a Schneider, Steffen  |e VerfasserIn  |4 aut 
700 1 |a Desch, Steffen  |e VerfasserIn  |4 aut 
700 1 |a Thiele, Holger  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t European heart journal - acute cardiovascular care  |d Oxford : Oxford University Press, 2012  |g 13(2024), 4 vom: Apr., Seite 335-346  |h Online-Ressource  |w (DE-627)718660390  |w (DE-600)2663340-1  |w (DE-576)39669909X  |x 2048-8734  |7 nnas  |a Current spectrum and outcomes of infarct-related cardiogenic shock insights from the CULPRIT-SHOCK registry and randomized controlled trial 
773 1 8 |g volume:13  |g year:2024  |g number:4  |g month:04  |g pages:335-346  |g extent:12  |a Current spectrum and outcomes of infarct-related cardiogenic shock insights from the CULPRIT-SHOCK registry and randomized controlled trial 
856 4 0 |u https://doi.org/10.1093/ehjacc/zuae020  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240823 
993 |a Article 
994 |a 2024 
998 |g 132322293  |a Akın, Ibrahim  |m 132322293:Akın, Ibrahim  |d 60000  |d 61000  |d 60000  |e 60000PA132322293  |e 61000PA132322293  |e 60000PA132322293  |k 0/60000/  |k 1/60000/61000/  |k 0/60000/  |p 4 
998 |g 1163486884  |a Zeymer, Uwe  |m 1163486884:Zeymer, Uwe  |p 1  |x j 
999 |a KXP-PPN1899443932  |e 4570002315 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"role":"aut","given":"Uwe","family":"Zeymer","display":"Zeymer, Uwe"},{"role":"aut","given":"Tobias","family":"Heer","display":"Heer, Tobias"},{"role":"aut","display":"Ouarrak, Taoufik","given":"Taoufik","family":"Ouarrak"},{"display":"Akın, Ibrahim","family":"Akın","given":"Ibrahim","role":"aut"},{"family":"Noc","given":"Marko","display":"Noc, Marko","role":"aut"},{"role":"aut","display":"Stepinska, Janina","given":"Janina","family":"Stepinska"},{"display":"Oldroyd, Keith","given":"Keith","family":"Oldroyd","role":"aut"},{"display":"Serpytis, Pranas","given":"Pranas","family":"Serpytis","role":"aut"},{"role":"aut","given":"Giles","family":"Montalescot","display":"Montalescot, Giles"},{"given":"Kurt","family":"Huber","display":"Huber, Kurt","role":"aut"},{"role":"aut","given":"Stephan","family":"Windecker","display":"Windecker, Stephan"},{"given":"Stefano","family":"Savonitto","display":"Savonitto, Stefano","role":"aut"},{"role":"aut","display":"Vrints, Christiaan","family":"Vrints","given":"Christiaan"},{"role":"aut","given":"Steffen","family":"Schneider","display":"Schneider, Steffen"},{"display":"Desch, Steffen","given":"Steffen","family":"Desch","role":"aut"},{"role":"aut","given":"Holger","family":"Thiele","display":"Thiele, Holger"}],"title":[{"title":"Current spectrum and outcomes of infarct-related cardiogenic shock","subtitle":"insights from the CULPRIT-SHOCK registry and randomized controlled trial","title_sort":"Current spectrum and outcomes of infarct-related cardiogenic shock"}],"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"April 2024"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Veröffentlicht: 13. Februar 2024","Gesehen am 23.08.2024"],"recId":"1899443932","id":{"eki":["1899443932"],"doi":["10.1093/ehjacc/zuae020"]},"name":{"displayForm":["Uwe Zeymer, Tobias Heer, Taoufik Ouarrak, Ibrahim Akin, Marko Noc, Janina Stepinska, Keith Oldroyd, Pranas Serpytis, Giles Montalescot, Kurt Huber, Stephan Windecker, Stefano Savonitto, Christiaan Vrints, Steffen Schneider, Steffen Desch, and Holger Thiele, on behalf of the CULPRIT-SHOCK Investigators"]},"relHost":[{"note":["Gesehen am 15.02.2023"],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"2012","dateIssuedDisp":"2012-","publisherPlace":"Oxford ; London","publisher":"Oxford University Press ; Sage Publishing"}],"title":[{"title":"European heart journal - acute cardiovascular care","title_sort":"European heart journal - acute cardiovascular care"}],"pubHistory":["1.2012 -"],"language":["eng"],"titleAlt":[{"title":"Acute Cardiovascular Care"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Current spectrum and outcomes of infarct-related cardiogenic shock insights from the CULPRIT-SHOCK registry and randomized controlled trialEuropean heart journal - acute cardiovascular care","part":{"issue":"4","year":"2024","text":"13(2024), 4 vom: Apr., Seite 335-346","pages":"335-346","volume":"13","extent":"12"},"name":{"displayForm":["European Society of Cardiology"]},"id":{"eki":["718660390"],"zdb":["2663340-1"],"issn":["2048-8734"]},"recId":"718660390"}],"physDesc":[{"extent":"12 S.","noteIll":"Illustrationen"}],"language":["eng"]} 
SRT |a ZEYMERUWEHCURRENTSPE2024